莫德纳和辉瑞的过敏反应

pcb

A serious adverse event (SAE) in human drug trials is defined as ANY untoward medical occurrence that at ANY dose

results in death,
is life-threatening
requires inpatient hospitalization or causes prolongation of existing hospitalization
results in persistent or significant disability/incapacity,
may have caused a congenital anomaly/birth defect, or
requires intervention to prevent permanent impairment or damage.